1 Market Overview

1.1 Product Overview and Scope of Oral Anti-diabetes Drugs

1.2 Classification of Oral Anti-diabetes Drugs by Type

1.2.1 Overview: Global Oral Anti-diabetes Drugs Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Oral Anti-diabetes Drugs Revenue Market Share by Type in 2020

1.2.3 Liquid

1.2.4 Capsule

1.2.5 Tablet

1.3 Global Oral Anti-diabetes Drugs Market by Distribution Channel

1.3.1 Overview: Global Oral Anti-diabetes Drugs Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Oral Anti-diabetes Drugs Market Size & Forecast

1.5 Global Oral Anti-diabetes Drugs Market Size and Forecast by Region

1.5.1 Global Oral Anti-diabetes Drugs Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Oral Anti-diabetes Drugs Market Size by Region, (2016-2021)

1.5.3 North America Oral Anti-diabetes Drugs Market Size and Prospect (2016-2026)

1.5.4 Europe Oral Anti-diabetes Drugs Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Oral Anti-diabetes Drugs Market Size and Prospect (2016-2026)

1.5.6 South America Oral Anti-diabetes Drugs Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Oral Anti-diabetes Drugs Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Oral Anti-diabetes Drugs Market Drivers

1.6.2 Oral Anti-diabetes Drugs Market Restraints

1.6.3 Oral Anti-diabetes Drugs Trends Analysis

2 Company Profiles

2.1 Sanofi

2.1.1 Sanofi Details

2.1.2 Sanofi Major Business

2.1.3 Sanofi Oral Anti-diabetes Drugs Product and Solutions

2.1.4 Sanofi Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Sanofi Recent Developments and Future Plans

2.2 Eli Lilly

2.2.1 Eli Lilly Details

2.2.2 Eli Lilly Major Business

2.2.3 Eli Lilly Oral Anti-diabetes Drugs Product and Solutions

2.2.4 Eli Lilly Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Eli Lilly Recent Developments and Future Plans

2.3 AstraZeneca plc

2.3.1 AstraZeneca plc Details

2.3.2 AstraZeneca plc Major Business

2.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Product and Solutions

2.3.4 AstraZeneca plc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 AstraZeneca plc Recent Developments and Future Plans

2.4 Astellas Pharma Inc

2.4.1 Astellas Pharma Inc Details

2.4.2 Astellas Pharma Inc Major Business

2.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Product and Solutions

2.4.4 Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Astellas Pharma Inc Recent Developments and Future Plans

2.5 Johnson & Johnson (Janssen Pharmaceuticals)

2.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Details

2.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Major Business

2.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product and Solutions

2.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments and Future Plans

2.6 Boehringer Ingelheim

2.6.1 Boehringer Ingelheim Details

2.6.2 Boehringer Ingelheim Major Business

2.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Product and Solutions

2.6.4 Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Boehringer Ingelheim Recent Developments and Future Plans

2.7 Merck

2.7.1 Merck Details

2.7.2 Merck Major Business

2.7.3 Merck Oral Anti-diabetes Drugs Product and Solutions

2.7.4 Merck Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Merck Recent Developments and Future Plans

2.8 Takeda

2.8.1 Takeda Details

2.8.2 Takeda Major Business

2.8.3 Takeda Oral Anti-diabetes Drugs Product and Solutions

2.8.4 Takeda Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Takeda Recent Developments and Future Plans

2.9 Bristol Myers Squibb

2.9.1 Bristol Myers Squibb Details

2.9.2 Bristol Myers Squibb Major Business

2.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Product and Solutions

2.9.4 Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Bristol Myers Squibb Recent Developments and Future Plans

2.10 Novartis

2.10.1 Novartis Details

2.10.2 Novartis Major Business

2.10.3 Novartis Oral Anti-diabetes Drugs Product and Solutions

2.10.4 Novartis Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Novartis Recent Developments and Future Plans

2.11 Pfizer

2.11.1 Pfizer Details

2.11.2 Pfizer Major Business

2.11.3 Pfizer Oral Anti-diabetes Drugs Product and Solutions

2.11.4 Pfizer Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pfizer Recent Developments and Future Plans

2.12 Abbott

2.12.1 Abbott Details

2.12.2 Abbott Major Business

2.12.3 Abbott Oral Anti-diabetes Drugs Product and Solutions

2.12.4 Abbott Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Abbott Recent Developments and Future Plans

2.13 Biocon

2.13.1 Biocon Details

2.13.2 Biocon Major Business

2.13.3 Biocon Oral Anti-diabetes Drugs Product and Solutions

2.13.4 Biocon Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Biocon Recent Developments and Future Plans

2.14 Sunpharma

2.14.1 Sunpharma Details

2.14.2 Sunpharma Major Business

2.14.3 Sunpharma Oral Anti-diabetes Drugs Product and Solutions

2.14.4 Sunpharma Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Sunpharma Recent Developments and Future Plans

2.15 Novo Nordisk

2.15.1 Novo Nordisk Details

2.15.2 Novo Nordisk Major Business

2.15.3 Novo Nordisk Oral Anti-diabetes Drugs Product and Solutions

2.15.4 Novo Nordisk Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Novo Nordisk Recent Developments and Future Plans

2.16 Piramal Healthcare

2.16.1 Piramal Healthcare Details

2.16.2 Piramal Healthcare Major Business

2.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Product and Solutions

2.16.4 Piramal Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Piramal Healthcare Recent Developments and Future Plans

2.17 Bayer Healthcare

2.17.1 Bayer Healthcare Details

2.17.2 Bayer Healthcare Major Business

2.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Product and Solutions

2.17.4 Bayer Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Bayer Healthcare Recent Developments and Future Plans

2.18 Dr. Reddy’s Laboratories Ltd

2.18.1 Dr. Reddy’s Laboratories Ltd Details

2.18.2 Dr. Reddy’s Laboratories Ltd Major Business

2.18.3 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product and Solutions

2.18.4 Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans

2.19 Glenmark Pharmaceuticals Ltd

2.19.1 Glenmark Pharmaceuticals Ltd Details

2.19.2 Glenmark Pharmaceuticals Ltd Major Business

2.19.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product and Solutions

2.19.4 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Glenmark Pharmaceuticals Ltd Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Oral Anti-diabetes Drugs Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Oral Anti-diabetes Drugs Players Market Share

3.2.2 Top 10 Oral Anti-diabetes Drugs Players Market Share

3.2.3 Market Competition Trend

3.3 Oral Anti-diabetes Drugs Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Oral Anti-diabetes Drugs Revenue and Market Share by Type (2016-2021)

4.2 Global Oral Anti-diabetes Drugs Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Oral Anti-diabetes Drugs Revenue Market Share by Application (2016-2021)

5.2 Oral Anti-diabetes Drugs Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Oral Anti-diabetes Drugs Revenue by Type (2016-2026)

6.2 North America Oral Anti-diabetes Drugs Revenue by Application (2016-2026)

6.3 North America Oral Anti-diabetes Drugs Market Size by Country

6.3.1 North America Oral Anti-diabetes Drugs Revenue by Country (2016-2026)

6.3.2 United States Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

6.3.3 Canada Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

6.3.4 Mexico Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Oral Anti-diabetes Drugs Revenue by Type (2016-2026)

7.2 Europe Oral Anti-diabetes Drugs Revenue by Application (2016-2026)

7.3 Europe Oral Anti-diabetes Drugs Market Size by Country

7.3.1 Europe Oral Anti-diabetes Drugs Revenue by Country (2016-2026)

7.3.2 Germany Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

7.3.3 France Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

7.3.5 Russia Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

7.3.6 Italy Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Oral Anti-diabetes Drugs Revenue by Type (2016-2026)

8.2 Asia-Pacific Oral Anti-diabetes Drugs Revenue by Application (2016-2026)

8.3 Asia-Pacific Oral Anti-diabetes Drugs Market Size by Region

8.3.1 Asia-Pacific Oral Anti-diabetes Drugs Revenue by Region (2016-2026)

8.3.2 China Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

8.3.3 Japan Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

8.3.4 South Korea Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

8.3.5 India Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

8.3.7 Australia Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Oral Anti-diabetes Drugs Revenue by Type (2016-2026)

9.2 South America Oral Anti-diabetes Drugs Revenue by Application (2016-2026)

9.3 South America Oral Anti-diabetes Drugs Market Size by Country

9.3.1 South America Oral Anti-diabetes Drugs Revenue by Country (2016-2026)

9.3.2 Brazil Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

9.3.3 Argentina Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Oral Anti-diabetes Drugs Revenue by Type (2016-2026)

10.2 Middle East & Africa Oral Anti-diabetes Drugs Revenue by Application (2016-2026)

10.3 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Country

10.3.1 Middle East & Africa Oral Anti-diabetes Drugs Revenue by Country (2016-2026)

10.3.2 Turkey Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

10.3.4 UAE Oral Anti-diabetes Drugs Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Oral Anti-diabetes Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Oral Anti-diabetes Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Oral Anti-diabetes Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Oral Anti-diabetes Drugs Revenue (USD Million) by Region (2016-2021)

Table 5. Global Oral Anti-diabetes Drugs Revenue Market Share by Region (2021-2026)

Table 6. Sanofi Corporate Information, Head Office, and Major Competitors

Table 7. Sanofi Major Business

Table 8. Sanofi Oral Anti-diabetes Drugs Product and Solutions

Table 9. Sanofi Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 11. Eli Lilly Major Business

Table 12. Eli Lilly Oral Anti-diabetes Drugs Product and Solutions

Table 13. Eli Lilly Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. AstraZeneca plc Corporate Information, Head Office, and Major Competitors

Table 15. AstraZeneca plc Major Business

Table 16. AstraZeneca plc Oral Anti-diabetes Drugs Product and Solutions

Table 17. AstraZeneca plc Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Astellas Pharma Inc Corporate Information, Head Office, and Major Competitors

Table 19. Astellas Pharma Inc Major Business

Table 20. Astellas Pharma Inc Oral Anti-diabetes Drugs Product and Solutions

Table 21. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Johnson & Johnson (Janssen Pharmaceuticals) Corporate Information, Head Office, and Major Competitors

Table 23. Johnson & Johnson (Janssen Pharmaceuticals) Major Business

Table 24. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product and Solutions

Table 25. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 27. Boehringer Ingelheim Major Business

Table 28. Boehringer Ingelheim Oral Anti-diabetes Drugs Product and Solutions

Table 29. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Merck Corporate Information, Head Office, and Major Competitors

Table 31. Merck Major Business

Table 32. Merck Oral Anti-diabetes Drugs Product and Solutions

Table 33. Merck Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Takeda Corporate Information, Head Office, and Major Competitors

Table 35. Takeda Major Business

Table 36. Takeda Oral Anti-diabetes Drugs Product and Solutions

Table 37. Takeda Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Bristol Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 39. Bristol Myers Squibb Major Business

Table 40. Bristol Myers Squibb Oral Anti-diabetes Drugs Product and Solutions

Table 41. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Novartis Corporate Information, Head Office, and Major Competitors

Table 43. Novartis Major Business

Table 44. Novartis Oral Anti-diabetes Drugs Product and Solutions

Table 45. Novartis Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pfizer Corporate Information, Head Office, and Major Competitors

Table 47. Pfizer Major Business

Table 48. Pfizer Oral Anti-diabetes Drugs Product and Solutions

Table 49. Pfizer Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Abbott Corporate Information, Head Office, and Major Competitors

Table 51. Abbott Major Business

Table 52. Abbott Oral Anti-diabetes Drugs Product and Solutions

Table 53. Abbott Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Biocon Corporate Information, Head Office, and Major Competitors

Table 55. Biocon Major Business

Table 56. Biocon Oral Anti-diabetes Drugs Product and Solutions

Table 57. Biocon Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Sunpharma Corporate Information, Head Office, and Major Competitors

Table 59. Sunpharma Major Business

Table 60. Sunpharma Oral Anti-diabetes Drugs Product and Solutions

Table 61. Sunpharma Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Novo Nordisk Corporate Information, Head Office, and Major Competitors

Table 63. Novo Nordisk Major Business

Table 64. Novo Nordisk Oral Anti-diabetes Drugs Product and Solutions

Table 65. Novo Nordisk Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Piramal Healthcare Corporate Information, Head Office, and Major Competitors

Table 67. Piramal Healthcare Major Business

Table 68. Piramal Healthcare Oral Anti-diabetes Drugs Product and Solutions

Table 69. Piramal Healthcare Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Bayer Healthcare Corporate Information, Head Office, and Major Competitors

Table 71. Bayer Healthcare Major Business

Table 72. Bayer Healthcare Oral Anti-diabetes Drugs Product and Solutions

Table 73. Bayer Healthcare Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Dr. Reddy’s Laboratories Ltd Corporate Information, Head Office, and Major Competitors

Table 75. Dr. Reddy’s Laboratories Ltd Major Business

Table 76. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Product and Solutions

Table 77. Dr. Reddy’s Laboratories Ltd Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Glenmark Pharmaceuticals Ltd Corporate Information, Head Office, and Major Competitors

Table 79. Glenmark Pharmaceuticals Ltd Major Business

Table 80. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product and Solutions

Table 81. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Global Oral Anti-diabetes Drugs Revenue (USD Million) by Players (2019-2021)

Table 83. Global Oral Anti-diabetes Drugs Revenue Share by Players (2019-2021)

Table 84. Breakdown of Oral Anti-diabetes Drugs by Company Type (Tier 1, Tier 2 and Tier 3)

Table 85. Oral Anti-diabetes Drugs Players Head Office, Products and Services Provided

Table 86. Oral Anti-diabetes Drugs Mergers & Acquisitions in the Past Five Years

Table 87. Oral Anti-diabetes Drugs New Entrants and Expansion Plans

Table 88. Global Oral Anti-diabetes Drugs Revenue (USD Million) by Type (2016-2021)

Table 89. Global Oral Anti-diabetes Drugs Revenue Share by Type (2016-2021)

Table 90. Global Oral Anti-diabetes Drugs Revenue Forecast by Type (2021-2026)

Table 91. Global Oral Anti-diabetes Drugs Revenue by Application (2016-2021)

Table 92. Global Oral Anti-diabetes Drugs Revenue Forecast by Application (2021-2026)

Table 93. North America Oral Anti-diabetes Drugs Revenue by Type (2016-2021) & (USD Million)

Table 94. North America Oral Anti-diabetes Drugs Revenue by Type (2021-2026) & (USD Million)

Table 95. North America Oral Anti-diabetes Drugs Revenue by Application (2016-2021) & (USD Million)

Table 96. North America Oral Anti-diabetes Drugs Revenue by Application (2021-2026) & (USD Million)

Table 97. North America Oral Anti-diabetes Drugs Revenue by Country (2016-2021) & (USD Million)

Table 98. North America Oral Anti-diabetes Drugs Revenue by Country (2021-2026) & (USD Million)

Table 99. Europe Oral Anti-diabetes Drugs Revenue by Type (2016-2021) & (USD Million)

Table 100. Europe Oral Anti-diabetes Drugs Revenue by Type (2021-2026) & (USD Million)

Table 101. Europe Oral Anti-diabetes Drugs Revenue by Application (2016-2021) & (USD Million)

Table 102. Europe Oral Anti-diabetes Drugs Revenue by Application (2021-2026) & (USD Million)

Table 103. Europe Oral Anti-diabetes Drugs Revenue by Country (2016-2021) & (USD Million)

Table 104. Europe Oral Anti-diabetes Drugs Revenue by Country (2021-2026) & (USD Million)

Table 105. Asia-Pacific Oral Anti-diabetes Drugs Revenue by Type (2016-2021) & (USD Million)

Table 106. Asia-Pacific Oral Anti-diabetes Drugs Revenue by Type (2021-2026) & (USD Million)

Table 107. Asia-Pacific Oral Anti-diabetes Drugs Revenue by Application (2016-2021) & (USD Million)

Table 108. Asia-Pacific Oral Anti-diabetes Drugs Revenue by Application (2021-2026) & (USD Million)

Table 109. Asia-Pacific Oral Anti-diabetes Drugs Revenue by Region (2016-2021) & (USD Million)

Table 110. Asia-Pacific Oral Anti-diabetes Drugs Revenue by Region (2021-2026) & (USD Million)

Table 111. South America Oral Anti-diabetes Drugs Revenue by Type (2016-2021) & (USD Million)

Table 112. South America Oral Anti-diabetes Drugs Revenue by Type (2021-2026) & (USD Million)

Table 113. South America Oral Anti-diabetes Drugs Revenue by Application (2016-2021) & (USD Million)

Table 114. South America Oral Anti-diabetes Drugs Revenue by Application (2021-2026) & (USD Million)

Table 115. South America Oral Anti-diabetes Drugs Revenue by Country (2016-2021) & (USD Million)

Table 116. South America Oral Anti-diabetes Drugs Revenue by Country (2021-2026) & (USD Million)

Table 117. Middle East & Africa Oral Anti-diabetes Drugs Revenue by Type (2016-2021) & (USD Million)

Table 118. Middle East & Africa Oral Anti-diabetes Drugs Revenue by Type (2021-2026) & (USD Million)

Table 119. Middle East & Africa Oral Anti-diabetes Drugs Revenue by Application (2016-2021) & (USD Million)

Table 120. Middle East & Africa Oral Anti-diabetes Drugs Revenue by Application (2021-2026) & (USD Million)

Table 121. Middle East & Africa Oral Anti-diabetes Drugs Revenue by Country (2016-2021) & (USD Million)

Table 122. Middle East & Africa Oral Anti-diabetes Drugs Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Oral Anti-diabetes Drugs Picture

Figure 2. Global Oral Anti-diabetes Drugs Revenue Market Share by Type in 2020

Figure 3. Liquid

Figure 4. Capsule

Figure 5. Tablet

Figure 6. Oral Anti-diabetes Drugs Revenue Market Share by Distribution Channel in 2020

Figure 7. Hospital Pharmacies Picture

Figure 8. Retail Pharmacies Picture

Figure 9. Online Pharmacies Picture

Figure 10. Global Oral Anti-diabetes Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Oral Anti-diabetes Drugs Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Oral Anti-diabetes Drugs Revenue Market Share by Region (2016-2026)

Figure 13. Global Oral Anti-diabetes Drugs Revenue Market Share by Region in 2020

Figure 14. North America Oral Anti-diabetes Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Oral Anti-diabetes Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Oral Anti-diabetes Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Oral Anti-diabetes Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Oral Anti-diabetes Drugs Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Oral Anti-diabetes Drugs Market Drivers

Figure 20. Oral Anti-diabetes Drugs Market Restraints

Figure 21. Oral Anti-diabetes Drugs Market Trends

Figure 22. Sanofi Recent Developments and Future Plans

Figure 23. Eli Lilly Recent Developments and Future Plans

Figure 24. AstraZeneca plc Recent Developments and Future Plans

Figure 25. Astellas Pharma Inc Recent Developments and Future Plans

Figure 26. Johnson & Johnson (Janssen Pharmaceuticals) Recent Developments and Future Plans

Figure 27. Boehringer Ingelheim Recent Developments and Future Plans

Figure 28. Merck Recent Developments and Future Plans

Figure 29. Takeda Recent Developments and Future Plans

Figure 30. Bristol Myers Squibb Recent Developments and Future Plans

Figure 31. Novartis Recent Developments and Future Plans

Figure 32. Pfizer Recent Developments and Future Plans

Figure 33. Abbott Recent Developments and Future Plans

Figure 34. Biocon Recent Developments and Future Plans

Figure 35. Sunpharma Recent Developments and Future Plans

Figure 36. Novo Nordisk Recent Developments and Future Plans

Figure 37. Piramal Healthcare Recent Developments and Future Plans

Figure 38. Bayer Healthcare Recent Developments and Future Plans

Figure 39. Dr. Reddy’s Laboratories Ltd Recent Developments and Future Plans

Figure 40. Glenmark Pharmaceuticals Ltd Recent Developments and Future Plans

Figure 41. Global Oral Anti-diabetes Drugs Revenue Share by Players in 2020

Figure 42. Oral Anti-diabetes Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 43. Global Top 3 Players Oral Anti-diabetes Drugs Revenue Market Share in 2020

Figure 44. Global Top 10 Players Oral Anti-diabetes Drugs Revenue Market Share in 2020

Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 46. Global Oral Anti-diabetes Drugs Revenue Share by Type in 2020

Figure 47. Global Oral Anti-diabetes Drugs Market Share Forecast by Type (2021-2026)

Figure 48. Global Oral Anti-diabetes Drugs Revenue Share by Application in 2020

Figure 49. Global Oral Anti-diabetes Drugs Market Share Forecast by Application (2021-2026)

Figure 50. North America Oral Anti-diabetes Drugs Sales Market Share by Type (2016-2026)

Figure 51. North America Oral Anti-diabetes Drugs Sales Market Share by Application (2016-2026)

Figure 52. North America Oral Anti-diabetes Drugs Revenue Market Share by Country (2016-2026)

Figure 53. United States Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Canada Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Mexico Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Europe Oral Anti-diabetes Drugs Sales Market Share by Type (2016-2026)

Figure 57. Europe Oral Anti-diabetes Drugs Sales Market Share by Application (2016-2026)

Figure 58. Europe Oral Anti-diabetes Drugs Revenue Market Share by Country (2016-2026)

Figure 59. Germany Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. France Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. United Kingdom Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Russia Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Italy Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Asia-Pacific Oral Anti-diabetes Drugs Sales Market Share by Type (2016-2026)

Figure 65. Asia-Pacific Oral Anti-diabetes Drugs Sales Market Share by Application (2016-2026)

Figure 66. Asia-Pacific Oral Anti-diabetes Drugs Revenue Market Share by Region (2016-2026)

Figure 67. China Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Japan Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South Korea Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. India Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Southeast Asia Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Australia Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South America Oral Anti-diabetes Drugs Sales Market Share by Type (2016-2026)

Figure 74. South America Oral Anti-diabetes Drugs Sales Market Share by Application (2016-2026)

Figure 75. South America Oral Anti-diabetes Drugs Revenue Market Share by Country (2016-2026)

Figure 76. Brazil Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Argentina Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Middle East and Africa Oral Anti-diabetes Drugs Sales Market Share by Type (2016-2026)

Figure 79. Middle East and Africa Oral Anti-diabetes Drugs Sales Market Share by Application (2016-2026)

Figure 80. Middle East and Africa Oral Anti-diabetes Drugs Revenue Market Share by Country (2016-2026)

Figure 81. Turkey Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Saudi Arabia Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. UAE Oral Anti-diabetes Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Methodology

Figure 85. Research Process and Data Source